Dr. Cenk Sahinalp

Dr. Cenk Sahinalp

B.Sc. Electrical Engineering, Bilkent University, Turkey 
Ph.D. Computer Science, University of Maryland, College Park

Clinical and Research Scientists

Professor and Canada Research Chair in Computational Genomics, School of Computing Science, Simon Fraser University


Dr. Cenk Sahinalp is a Professor and the Canada Research Chair in Computational Genomics at the School of Computing Science at Simon Fraser University. He is also the director of the Computational Methods for the Analysis of the Diversity and Dynamics of Genomes (MADD-Gen) Graduate program in Vancouver, the first bioinformatics program focusing on big data challenges in genomics, bringing together more than 20 investigators in SFU, the Vancouver Prostate Centre and the BC Cancer Research Centre.

His research focuses primarily on computational genomics and biomolecular sequence analysis, especially in the context of cancer, as well as non-coding RNA structure and functionality and network biology.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


2016 Step Up team

Step Up Challenge fundraiser: February 25, 2018

The annual Step Up Challenge, raising funds for Prostate Cancer Canada, takes place in Vancouver on Sunday February 25. Click here to sponsor our relay team as they climbs 379 floors. Click here to volunteer to help with the event.

It's a Snow Day poster

It's A Snow Day at Mt. Seymour: March 9

Mt. Seymour is hosting It's A Snow Day, a fundraiser for Prostate Cancer Foundation BC, on Friday March 9. The event will include slope time, a reception, and a silent auction. Click here for more details including how to register, donate and/or sponsor.




Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.